Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
A. John Camm & Keith A. A. Fox. (2018) Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban. Current Medical Research and Opinion 34:11, pages 1945-1957.
Read now
Read now
Ylenia Ingrasciotta, Salvatore Crisafulli, Valeria Pizzimenti, Ilaria Marcianò, Anna Mancuso, Giuseppe Andò, Salvatore Corrao, Piera Capranzano & Gianluca Trifirò. (2018) Pharmacokinetics of new oral anticoagulants: implications for use in routine care. Expert Opinion on Drug Metabolism & Toxicology 14:10, pages 1057-1069.
Read now
Read now
Emilio Márquez-Contreras, Nieves Martell-Claros, Sara Márquez-Rivero, Enrique Hermida-Campa, Carmen Gracia-Diez, Eugenio Sanchez-López & Vicente Gil-Guillén. (2018) Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study). Current Medical Research and Opinion 34:7, pages 1301-1308.
Read now
Read now
José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Vanessa Roldán, Francisco Marín & Gregory Y.H. Lip. (2017) Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opinion on Drug Safety 16:9, pages 1051-1062.
Read now
Read now
Walter Ageno, Jan Beyer-Westendorf & Andrea Rubboli. (2017) Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation. Expert Opinion on Pharmacotherapy 18:13, pages 1325-1332.
Read now
Read now
Craig Coleman, Zhong Yuan, Jeff Schein, Concetta Crivera, Veronica Ashton, François Laliberté, Patrick Lefebvre & Eric D. Peterson. (2017) Importance of balancing follow-up time and impact of oral-anticoagulant users’ selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban. Current Medical Research and Opinion 33:6, pages 1033-1043.
Read now
Read now
Emilio Márquez-Contreras, Nieves Martell-Carlos, Vincente Gil-Guillén, Mariano De La Figuera-Von Wichmann, Eugenio Sanchez-López, Sara Márquez-Rivero, Ines Gil-Gil & Enrique Hermida-Campa. (2016) Therapeutic compliance with rivaroxaban in preventing stroke in patients with non-valvular atrial fibrillation: CUMRIVAFA study. Current Medical Research and Opinion 32:12, pages 2013-2020.
Read now
Read now
Articles from other publishers (36)
Joan T RichersonTodd H. WagnerThad AbramsKelly SkeltonKousick BiswasSamantha IllarmoFrances McSherryMichael T. FallonAustin FraktSteven PizerKathryn M. MagruderShirley GroerPatricia A. DornGrant D. HuangEileen M. Stock. (2023) Therapeutic and Economic Benefits of Service Dogs Versus Emotional Support Dogs for Veterans With PTSD. Psychiatric Services 74:8, pages 790-800.
Crossref
Crossref
Prachi Arora, Maria Muehrcke, Molly Russell & Saurabh Ghanekar. (2023) Utilization outcomes of direct oral anticoagulants in Medicare patients. Research in Social and Administrative Pharmacy.
Crossref
Crossref
Prachi Arora, Maria Muehrcke, Molly Russell & Rasitha Jayasekare. (2022) Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants. Journal of Comparative Effectiveness Research 11:15, pages 1105-1120.
Crossref
Crossref
Lachlan L. Dalli, Monique F. Kilkenny, Isabelle Arnet, Frank M. Sanfilippo, Doyle M. Cummings, Moira K. Kapral, Joosup Kim, Jan Cameron, Kevin Y. Yap, Melanie Greenland & Dominique A. Cadilhac. (2022) Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN‐SPIDERS. British Journal of Clinical Pharmacology 88:10, pages 4427-4442.
Crossref
Crossref
Eleni Vrana, Anastasios Kartas, Athanasios Samaras, Dimitra Vasdeki, Evropi Forozidou, Evangelos Liampas, Haralambos Karvounis, George Giannakoulas & Apostolos Tzikas. (2022) Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation. Journal of Cardiovascular Medicine 23:3, pages 176-182.
Crossref
Crossref
Jaejin An, Zoe Bider, Tiffany Q. Luong, T. Craig Cheetham, Daniel T. Lang, Heidi Fischer & Kristi Reynolds. (2021) Long‐Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation. Journal of the American Heart Association 10:21.
Crossref
Crossref
Catarina Brízido, António Miguel Ferreira, Pedro Lopes, Christopher Strong, Gustavo Sá Mendes, Francisco Fernandes Gama, Anaí Durazzo, Gustavo Rocha Rodrigues, Daniel Matos, Sara Guerreiro, Sérgio Madeira, Jorge Ferreira, Pedro Adragão & Miguel Mendes. (2021) Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation – A real world analysis. Revista Portuguesa de Cardiologia (English Edition) 40:9, pages 669-675.
Crossref
Crossref
Catarina Brízido, António Miguel Ferreira, Pedro Lopes, Christopher Strong, Gustavo Sá Mendes, Francisco Fernandes Gama, Anaí Durazzo, Gustavo Rocha Rodrigues, Daniel Matos, Sara Guerreiro, Sérgio Madeira, Jorge Ferreira, Pedro Adragão & Miguel Mendes. (2021) Adesão à terapêutica com anticoagulantes diretos em doentes com fibrilhação auricular não valvular – uma análise de mundo real. Revista Portuguesa de Cardiologia 40:9, pages 669-675.
Crossref
Crossref
Gilda D. Zielinski, Nienke van Rein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van der Meer, Menno V. Huisman, Suzanne C. Cannegieter & Willem M. Lijfering. (2021) Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study. Pharmacoepidemiology and Drug Safety 30:8, pages 1027-1036.
Crossref
Crossref
Tsuyoshi Shiga, Toshimi Kimura, Noritoshi Fukushima, Yuji Yoshiyama, Kazunori Iwade, Fumiaki Mori, Yoichi Ajiro, Shoji Haruta, Yuichiro Yamada, Emi Sawada & Nobuhisa Hagiwara. (2021) Electronic monitoring of adherence to once‐daily and twice‐daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP‐AF trial. Journal of Arrhythmia 37:3, pages 616-625.
Crossref
Crossref
Apostolos Tzikas, Athanasios Samaras, Anastasios Kartas, Dimitra Vasdeki, George Fotos, George Dividis, Eleni Paschou, Evropi Forozidou, Paraskevi Tsoukra, Eleni Kotsi, Ioannis Goulas, Haralambos Karvounis & George Giannakoulas. (2021) Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial. European Heart Journal - Cardiovascular Pharmacotherapy 7:FI1, pages f63-f71.
Crossref
Crossref
Michael Johnsrud, Kristin Richards, Steve Arcona, Rahul Sasané & Matthew Leoni. (2021) An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population. Clinical Parkinsonism & Related Disorders 5, pages 100109.
Crossref
Crossref
Monika Kozieł, Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Axel Brandes, Miney Paquette, Kristina Zint, Lionel Riou França, Shihai Lu, Dorothee B. Bartels, Menno V. Huisman & Gregory Y. H. Lip. (2020) Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up. Journal of Clinical Medicine 9:6, pages 1969.
Crossref
Crossref
Shahrzad Salmasi, Peter S Loewen, Rachel Tandun, Jason G Andrade & Mary A De Vera. (2020) Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open 10:4, pages e034778.
Crossref
Crossref
Inmaculada Hernandez, Meiqi He, Maria M. Brooks, Samir Saba & Walid F. Gellad. (2019) Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation. American Journal of Cardiovascular Drugs 20:2, pages 199-207.
Crossref
Crossref
Sylvie Perreault, Simon Denus, Brian White‐Guay, Robert Côté, Mireille E. Schnitzer, Marie‐Pierre Dubé, Marc Dorais & Jean‐Claude Tardif. (2019) Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:1, pages 40-54.
Crossref
Crossref
S. G. Kanorskii. (2019) How to maintain an adherence to oral anticoagulant in a patient with atrial fibrillation?. Kardiologiia 59:11, pages 76-83.
Crossref
Crossref
Phuong N. Pham & Joshua D. Brown. (2019) Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Ami Vyas, Emily Patry, Norma Owens, Nicholas Belviso & Stephen J. Kogut. (2019) Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults. Drugs - Real World Outcomes 6:4, pages 173-181.
Crossref
Crossref
O. D. OstroumovaA. I. Kochetkov, S. P. Korchagina, T. M. OstroumovaM. S. Chernyaeva & A. A. Kirichenko. (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation. Rational Pharmacotherapy in Cardiology 15:5, pages 713-724.
Crossref
Crossref
Inmaculada Hernandez, Meiqi He, Nemin Chen, Maria M. Brooks, Samir Saba & Walid F. Gellad. (2019) Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation. Journal of the American Heart Association 8:12.
Crossref
Crossref
Abdulla Shehab, Akshaya S. Bhagavathula, Tamrat B. Abebe, Tadesse M. Abegaz, Asim A. Elnour, Hani M. Sabbour, Masood Uzzafer, Ahmed Hersi & Adel K. Hamad. (2019) Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis. Current Vascular Pharmacology 17:4, pages 341-349.
Crossref
Crossref
Jin-Kyu Park, Jun Kim, Yong Soo Baek, So-Ryoung Lee, You Mi Hwang, Tae-Hoon Kim, Dae In Lee, Ki Hong Lee, Jaemin Shim & Boyoung Joung. (2019) 2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up. The Korean Journal of Medicine 94:1, pages 17-39.
Crossref
Crossref
Isabel Hurtado-Navarro, Aníbal García-Sempere, Clara Rodríguez-Bernal, Yared Santa-Ana-Tellez, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2018) Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain. Frontiers in Pharmacology 9.
Crossref
Crossref
Clara L Rodríguez-Bernal, Aníbal García-Sempere, Isabel Hurtado, Yared Santa-Ana, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2018) Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis. BMJ Open 8:12, pages e025102.
Crossref
Crossref
Chinmay G. DeshpandeStephen KogutCynthia Willey. (2018) Real-World Health Care Costs Based on Medication Adherence and Risk of Stroke and Bleeding in Patients Treated with Novel Anticoagulant Therapy. Journal of Managed Care & Specialty Pharmacy 24:5, pages 430-439.
Crossref
Crossref
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Ronan Collins, A John Camm, Hein Heidbüchel, Gregory Y H Lip, Jeffrey Weitz, Laurent Fauchier, Deirdre Lane, Giuseppe Boriani, Andreas Goette, Roberto Keegan, Robert MacFadyen, Chern-En Chiang, Boyoung Joung & Wataru Shimizu. (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European Heart Journal 39:16, pages 1330-1393.
Crossref
Crossref
Beenish S. Manzoor, Todd A. Lee, Lisa K. Sharp, Surrey M. Walton, William L. Galanter & Edith A. Nutescu. (2017) Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:10, pages 1221-1230.
Crossref
Crossref
Joshua D. BrownAnand R. ShewaleJeffery C. Talbert. (2017) Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data. Journal of Managed Care & Specialty Pharmacy 23:9, pages 958-967.
Crossref
Crossref
Emilio Márquez-Contreras, Nieves Martell-Claros, Vicente Gil-Guillén, Mariano De la Figuera-Von Wichmann, Eugenio Sánchez-López, Ines Gil-Gil & Sara Márquez-Rivero. (2017) Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance. Quality of Life Research 26:3, pages 647-654.
Crossref
Crossref
Joshua D. BrownAnand R. ShewaleJeffery C. Talbert. (2016) Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy 22:11, pages 1319-1329.
Crossref
Crossref
Kehinde O. Obamiro, Leanne Chalmers & Luke R. E. Bereznicki. (2016) A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation. American Journal of Cardiovascular Drugs 16:5, pages 349-363.
Crossref
Crossref
John K. Abdou, Vivian Auyeung, Jignesh P. Patel & Roopen Arya. (2016) Adherence to long-term anticoagulation treatment, what is known and what the future might hold. British Journal of Haematology 174:1, pages 30-42.
Crossref
Crossref
Marek Jauß, Sibylle Kaiser & Christian Tanislav. (2016) Neue Einsichten durch Real-World-Daten zu oralen Non-Vitamin-K-Antikoagulanzien. InFo Neurologie & Psychiatrie 18:6, pages 46-60.
Crossref
Crossref
Alan D. Bell, Peter Gross, Michael Heffernan, Yan Deschaintre, Jean-Francois Roux, Daniel M. Purdham & Ashfaq Shuaib. (2016) Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation. The American Journal of Cardiology 117:7, pages 1107-1111.
Crossref
Crossref
Yi Feng Lai, Jun Kai Neo, Mcvin HH Cheen, Ming Chai Kong, Bee Choo Tai & Heng Joo Ng. (2016) Comparison of Medication Adherence and Treatment Persistence between New Oral Anticoagulant and Warfarin among Patients. Annals of the Academy of Medicine, Singapore 45:1, pages 12-17.
Crossref
Crossref